Tech Company Financing Transactions
Pelage Pharmaceuticals Funding Round
Pelage Pharmaceuticals closed a $16.8 million Series A funding round on 2/27/2024. Backers included GV, Main Street Advisors and Visionary Venture Fund.
Transaction Overview
Company Name
Announced On
2/27/2024
Transaction Type
Venture Equity
Amount
$16,750,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance a first-in-class treatment for androgenetic alopecia or pattern baldness, and other types of alopecia including chemotherapy-induced hair loss.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
907 Westwood Boulevard 384
Los Angeles, CA 90024
USA
Los Angeles, CA 90024
USA
Phone
Undisclosed
Website
Email Address
Overview
At Pelage, our goal is to deliver a clinically-tested treatment grounded in innovative science for all genders, skin types, and hair types. Based on breakthrough discoveries by Pelage co-founders, we activate hair growth through a first-in-class mechanism that targets the metabolism of hair follicle stem cells.?
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Gil
Chief Medical Officer
Qing Weng
Co-Founder
Heather Christofk
Co-Founder
Michael Jung
President
William Lowry
Browse more venture capital transactions:
Prev: 2/27/2024: Campfire venture capital transaction
Next: 2/27/2024: Inkitt venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs